Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/29223984/ below:

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017

• PMID: 29223984
• DOI: 10.6004/jnccn.2017.0176

Item in Clipboard

Samir Gupta et al. J Natl Compr Canc Netw. 2017 Dec.

• PMID: 29223984
• DOI: 10.6004/jnccn.2017.0176

Item in Clipboard

The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal provide recommendations for the management of patients with high-risk syndromes associated with an increased risk of colorectal cancer (CRC). The NCCN Panel for Genetic/Familial High-Risk Assessment: Colorectal meets at least annually to assess comments from reviewers within their institutions, examine relevant data, and reevaluate and update their recommendations. These NCCN Guidelines Insights focus on genes newly associated with CRC risk on multigene panels, the associated evidence, and currently recommended management strategies.

Copyright © 2017 by the National Comprehensive Cancer Network.

PubMed Disclaimer

• NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

  Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S, Garber JE, Kauff ND, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Merajver SD, Offit K, Pal T, Reiser G, Shannon KM, Swisher E, Vinayak S, Voian NC, Weitzel JN, Wick MJ, Wiesner GL, Dwyer M, Darlow S. Daly MB, et al. J Natl Compr Canc Netw. 2017 Jan;15(1):9-20. doi: 10.6004/jnccn.2017.0003. J Natl Compr Canc Netw. 2017. PMID: 28040716

• NCCN Guidelines Insights: Colorectal Cancer Screening, Version 1.2018.

  Provenzale D, Gupta S, Ahnen DJ, Markowitz AJ, Chung DC, Mayer RJ, Regenbogen SE, Blanco AM, Bray T, Cooper G, Early DS, Ford JM, Giardiello FM, Grady W, Hall MJ, Halverson AL, Hamilton SR, Hampel H, Klapman JB, Larson DW, Lazenby AJ, Llor X, Lynch PM, Mikkelson J, Ness RM, Slavin TP, Sugandha S, Weiss JM, Dwyer MA, Ogba N. Provenzale D, et al. J Natl Compr Canc Netw. 2018 Aug;16(8):939-949. doi: 10.6004/jnccn.2018.0067. J Natl Compr Canc Netw. 2018. PMID: 30099370

• NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021.

  Weiss JM, Gupta S, Burke CA, Axell L, Chen LM, Chung DC, Clayback KM, Dallas S, Felder S, Gbolahan O, Giardiello FM, Grady W, Hall MJ, Hampel H, Hodan R, Idos G, Kanth P, Katona B, Lamps L, Llor X, Lynch PM, Markowitz AJ, Pirzadeh-Miller S, Samadder NJ, Shibata D, Swanson BJ, Szymaniak BM, Wiesner GL, Wolf A, Yurgelun MB, Zakhour M, Darlow SD, Dwyer MA, Campbell M. Weiss JM, et al. J Natl Compr Canc Netw. 2021 Oct 15;19(10):1122-1132. doi: 10.1164/jnccn.2021.0048. J Natl Compr Canc Netw. 2021. PMID: 34666312

• Genetic predisposition to colorectal cancer: Implications for treatment and prevention.

  Stoffel EM, Yurgelun MB. Stoffel EM, et al. Semin Oncol. 2016 Oct;43(5):536-542. doi: 10.1053/j.seminoncol.2016.08.002. Epub 2016 Sep 1. Semin Oncol. 2016. PMID: 27899184 Review.

• Update on Hereditary Colorectal Cancer: Improving the Clinical Utility of Multigene Panel Testing.

  Lorans M, Dow E, Macrae FA, Winship IM, Buchanan DD. Lorans M, et al. Clin Colorectal Cancer. 2018 Jun;17(2):e293-e305. doi: 10.1016/j.clcc.2018.01.001. Epub 2018 Jan 11. Clin Colorectal Cancer. 2018. PMID: 29454559 Review.

• Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer.

  Cadoo KA, Mandelker DL, Mukherjee S, Stewart C, DeLair D, Ravichandran V, Srinivasan P, Hurley D, Kemel Y, Arnold AG, Sheehan M, Pradhan N, Joseph V, Chi DS, Gardner GJ, Jewell EL, Leitao MM Jr, Long Roche K, Mueller JJ, Sonoda Y, Zivanovic O, Walsh M, Carlo MI, Berger MF, Hyman D, Zhang L, Robson ME, Offit K, Aghajanian C, Rustum NRA, Stadler Z. Cadoo KA, et al. JCO Precis Oncol. 2019;3:PO.18.00338. doi: 10.1200/po.18.00338. Epub 2019 Apr 25. JCO Precis Oncol. 2019. PMID: 32775946 Free PMC article.

• Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).

  Monahan KJ, Bradshaw N, Dolwani S, Desouza B, Dunlop MG, East JE, Ilyas M, Kaur A, Lalloo F, Latchford A, Rutter MD, Tomlinson I, Thomas HJW, Hill J; Hereditary CRC guidelines eDelphi consensus group. Monahan KJ, et al. Gut. 2020 Mar;69(3):411-444. doi: 10.1136/gutjnl-2019-319915. Epub 2019 Nov 28. Gut. 2020. PMID: 31780574 Free PMC article.

• Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.

  West AH, Blazer KR, Stoll J, Jones M, Weipert CM, Nielsen SM, Kupfer SS, Weitzel JN, Olopade OI. West AH, et al. Fam Cancer. 2018 Oct;17(4):495-505. doi: 10.1007/s10689-018-0070-x. Fam Cancer. 2018. PMID: 29445900 Free PMC article.

• Prevalence and characteristics of patients with upper urinary tract urothelial carcinoma having potential Lynch syndrome identified by immunohistochemical universal screening and Amsterdam criteria II.

  Tanabe K, Nakanishi Y, Okubo N, Matsumoto S, Umino Y, Kataoka M, Yajima S, Yoshida T, Miyazaki S, Kuwata T, Ishii G, Watanabe R, Masuda H. Tanabe K, et al. BMC Cancer. 2023 Oct 5;23(1):940. doi: 10.1186/s12885-023-11460-7. BMC Cancer. 2023. PMID: 37798659 Free PMC article.

• Development and validation of next generation sequencing based 35-gene hereditary cancer panel.

  Chan W, Lee M, Yeo ZX, Ying D, Grimaldi KA, Pickering C, Yang MMS, Sundaram SK, Tzang LCH. Chan W, et al. Hered Cancer Clin Pract. 2020 Apr 28;18:9. doi: 10.1186/s13053-020-00141-2. eCollection 2020. Hered Cancer Clin Pract. 2020. PMID: 32368312 Free PMC article.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3